Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis

Figure 6

Angiogenesis and macrophage accumulation in visceral peritoneum. Macrophage accumulation (Ed2 positive staining) in omentum (a) and mesentery (b) and angiogenesis (CD31 positive staining) in omentum (c) and mesentery (d) after 5 weeks of PDF exposure and paricalcitol treatment. Representative examples of the omentum with ED2 in green and CD31 in red of control rat (group I), PDF-exposed rat (group III), and PDF-exposed rat treated with paricalcitol (group IV) (e). All data presented as median and interquartiles. Whiskers indicate the extremes. ; .

(a)

(b)

(c)

(d)

(e)